| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.09 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |